Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
AKT2	PKBβ	ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 64: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: AB_2685278"	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 267.4;Oligodendrocyte precursor cells: 415.4"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"Neuroblastoma: 81.3"	"Colon - Enteric glia cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 32: Neurons - Synaptic function"	"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 2085.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Lung - Mitotic cells (Lung), Skin - Keratinocyte (granular), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 54: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400494-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Enzymes"	"Cluster 10: Neurons & Oligodendrocytes - Nervous system development"	Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 281.0;Salivary duct cells: 238.8;Syncytiotrophoblasts: 433.6"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Fibroblasts, Prostate - Prostate basal glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	88000000		"Cluster 31: Skin - Epidermis development"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 65: Fibroblasts - ECM organization"	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 837.2;Esophageal cancer: 442.3;Gastric cancer: 212.0"	"Lung - Alveolar cells type 1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 5: Bronchus - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 87.1;Endothelial cells: 103.9;granulocytes: 26.0;Microglial cells: 85.7"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"Leukemia: 24.7;prostate cancer: 23.9"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 66: Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Adipocytes: 23.7;Endothelial cells: 36.2;Extravillous trophoblasts: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cancer enhanced"	"Detected in many"		"Sarcoma: 6.0"	"Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: TE 441.T - Unknown function"	"Cluster 66: Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Thyroid - Fibroblasts"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA059474, HPA066898, CAB080219, CAB080220"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 11: Non-specific - Transcription"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, CAB080219: , CAB080220: , HPA059474: AB_2684030, HPA066898: "	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051994	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Intellectual disability, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Supported	"Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 64: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"
LMO1	"RBTN1, RHOM1, TTG1"	ENSG00000166407	"LIM domain only 1"	P25800	11	8224309-8268716	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.8;skeletal muscle: 29.3;tongue: 12.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 28.0;Early spermatids: 63.3;Horizontal cells: 14.7;Pancreatic endocrine cells: 53.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 13.2;Neuroblastoma: 20.1"	"Pancreas - Alpha cells, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 47: Retina - Visual perception"	"Cluster 49: Early spermatids - Spermatogenesis"				"unprognostic (3.74e-3)"	"unprognostic (1.45e-1)"		"unprognostic (4.75e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.37e-1)"		"unprognostic (1.98e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.36e-12)"	"unprognostic (1.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.13e-2)"
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808177-68850686	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 254.8;Skeletal myocytes: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303, CAB079977"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"	Nucleoplasm	Cytosol	"CAB000086: AB_563872, CAB016303: AB_627920, CAB079977: "	"unprognostic (1.16e-1)"	"prognostic favorable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"
MDM4	"HDMX, MDMX"	ENSG00000198625	"MDM4 regulator of p53"	O15151	1	204516379-204558120	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018919, HPA048821"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: Non-specific - RNA binding"	"Cluster 64: Non-specific - Transcription"	Nucleoplasm		"HPA018919: AB_1853694, HPA048821: AB_2680531"	"unprognostic (4.63e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.87e-4)"	"prognostic unfavorable (7.06e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (2.49e-4)"
MITF	"bHLHe32, MI, WS2, WS2A"	ENSG00000187098	"Melanocyte inducing transcription factor"	O75030	3	69739464-69968336	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Albinism, Cancer-related genes, Deafness, Disease variant, Microphthalmia, Osteopetrosis, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 137.5;Melanocytes: 837.7;Oligodendrocyte precursor cells: 159.8;Oligodendrocytes: 226.9"	"Cancer enriched"	"Detected in all"	4	"melanoma: 39.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 5.2;classical monocyte: 9.4;intermediate monocyte: 3.3;myeloid DC: 6.1;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.1;granulocytes: 5.2;monocytes: 9.4"	"Cancer enriched"	"Detected in all"	6	"skin cancer: 126.0"	"Breast - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002578, HPA003259"	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 25: Schwann cells & Melanocytes - Mixed function"			"CAB002578: AB_564111, HPA003259: AB_1079381"	"unprognostic (3.29e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.35e-10)"	"unprognostic (6.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127742951	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 254.6;skin 1: 289.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 608.5;Basal squamous epithelial cells: 1003.2;Squamous epithelial cells: 684.3;Suprabasal keratinocytes: 640.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 22: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 67.8;skin 1: 41.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.7;dendritic cells: 36.6;Squamous epithelial cells: 34.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	72	"dendritic cells: 22.8;monocytes: 17.3"	"Group enriched"	"Detected in many"	4	"lung cancer: 60.5;Myeloma: 32.5"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 22: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940550-15947007	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 9.5"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 92.6;Granulosa cells: 25.6"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	19	"Neuroblastoma: 760.6"	"Skin - Inner root sheath cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 54: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA057420: AB_2683434"	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lung: 53.1;thyroid gland: 172.4"	"Group enriched"	"Detected in some"	11	"Alveolar cells type 1: 208.2;Alveolar cells type 2: 304.8"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Region enhanced"	"Detected in many"		"thalamus: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"lung cancer: 27.9;prostate cancer: 29.7;thyroid cancer: 36.3"	"Lung - Alveolar cells type 2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.2;hypothalamus: 10.2"	"Group enriched"	"Detected in some"	13	"basal ganglia: 4.3;hypothalamus: 10.4"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 46: Non-specific - Unknown function"	"Cluster 41: Alveolar cells - Lung function"	"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269704-38382272	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018893	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 1: T-cells - Immune response"	Mitochondria	Nucleoplasm	"HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 25.4;granulocytes: 30.0;Horizontal cells: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Group enriched"	"Detected in some"	6	"Leukemia: 8.5;Neuroblastoma: 17.7"	"Heart muscle - Fibroblasts, Kidney - Intercalated cells, Lung - Mast cells, Stomach - Fibroblasts"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570, CAB080140"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 46: Granulocytes - Mast cell degranulation"	"Vesicles, Cytosol"		"CAB004606: AB_628397, CAB080140: , HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 66: Endothelial cells - Angiogenesis"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664125	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 175.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.1"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002639, HPA002640, CAB019291"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 5: Non-specific - Unknown function"	"Cluster 17: Granulosa cells - Transcription regulation"	"Plasma membrane, Cytosol"		"CAB019291: , HPA002639: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"
REL	"c-Rel, I-Rel"	ENSG00000162924	"REL proto-oncogene, NF-kB subunit"	Q04864	2	60881521-60931612	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 405.2;Langerhans cells: 1206.7;monocytes: 507.2;NK-cells: 335.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"lymphoma: 32.0"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004404	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"			"CAB004404: AB_670194"	"unprognostic (2.77e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.66e-2)"
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 288.3;Muller glia cells: 310.6;Respiratory ciliated cells: 83.5;Schwann cells: 124.5;Squamous epithelial cells: 212.2"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Enteric glia cells, Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: DU4475 - Unknown function"	"Cluster 68: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"